These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 12388859)

  • 1. ICH guidelines--implementation of the 3Rs (refinement, reduction, and replacement): incorporating best scientific practices into the regulatory process.
    Ohno Y
    ILAR J; 2002; 43 Suppl():S95-8. PubMed ID: 12388859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory Acceptance of Alternative Methods in the Development and Approval of Pharmaceuticals.
    Beken S; Kasper P; van der Laan JW
    Adv Exp Med Biol; 2016; 856():33-64. PubMed ID: 27671719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles and guidelines for the development of a science-based decision making process facilitating the implementation of the 3Rs by governmental regulators.
    Gauthier C
    ILAR J; 2002; 43 Suppl():S99-S104. PubMed ID: 12388860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Inhalation Toxicologists' (AIT) review of regulatory aspects for inhalation toxicology studies.
    Jones DR; Baldrick P
    Inhal Toxicol; 2013 Feb; 25(2):84-90. PubMed ID: 23363040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for safety evaluation using nonrodent species.
    Weekley LB; Guittin P; Chamberland G
    ILAR J; 2002; 43 Suppl():S118-22. PubMed ID: 12388864
    [No Abstract]   [Full Text] [Related]  

  • 7. Implementation of the 3Rs (refinement, reduction, and replacement): validation and regulatory acceptance considerations for alternative toxicological test methods.
    Schechtman LM
    ILAR J; 2002; 43 Suppl():S85-94. PubMed ID: 12388858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Industry perspectives on ICH guidelines.
    Rockhold FW
    Stat Med; 2002 Oct; 21(19):2949-57. PubMed ID: 12325111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future improvements and implementation of animal care practices within the animal testing regulatory environment.
    Guittin P; Decelle T
    ILAR J; 2002; 43 Suppl():S80-4. PubMed ID: 12388857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Replacement of dogs as research animals for the approval testing of plant protection products].
    Box RJ
    ALTEX; 2006; 23(1):24-7. PubMed ID: 16477345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Investigators' Brochure: a comparison of the draft international conference on harmonisation guideline with current Food and Drug Administration requirements.
    Cocchetto DM
    Qual Assur; 1995 Dec; 4(4):240-6. PubMed ID: 8890349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional Differences During the ICH Regulatory Consultation Process Between the EU, US, and Japan.
    Torqui A; Macau AM
    Ther Innov Regul Sci; 2018 Jul; 52(4):438-441. PubMed ID: 29714552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical concepts in the planning and evaluation of drug safety from clinical trials in drug development: issues of international harmonization.
    O'Neill RT
    Stat Med; 1995 May 15-30; 14(9-10):117-27. PubMed ID: 7569506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal use in the safety evaluation of chemicals: harmonization and emerging needs.
    Spielmann H
    ILAR J; 2002; 43 Suppl():S11-7. PubMed ID: 12388845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for acute systemic toxicity testing.
    Stitzel KA; Spielmann H; Griffin G
    ILAR J; 2002; 43 Suppl():S108-11. PubMed ID: 12388862
    [No Abstract]   [Full Text] [Related]  

  • 17. International Conference on Harmonisation; guidance on S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals intended for Human Use; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Jun; 77(110):33748-9. PubMed ID: 22675782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for subchronic/chronic toxicity and carcinogenicity testing.
    Combes R; Schechtman L; Stokes WS; Blakey D
    ILAR J; 2002; 43 Suppl():S112-7. PubMed ID: 12388863
    [No Abstract]   [Full Text] [Related]  

  • 19. Refinement, reduction, and replacement of animal use for regulatory testing: future improvements and implementation within the regulatory framework.
    Richmond J
    ILAR J; 2002; 43 Suppl():S63-8. PubMed ID: 12388854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact analysis of ICH S9 on non-clinical development of anticancer drugs.
    Bonelli M; Di Giuseppe F; Beken S
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):361-6. PubMed ID: 26232707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.